Ukraine’s unprecedented drone rescue of a wounded soldier from the battlefield has shown once again how battlefield necessity can spur innovation. The operation was revealed just days after separate Ukrainian drones designed for casualty evacuation were deployed for frontline testing—taking a step beyond the US military’s decades of experimentation with similar concepts.

The drone evacuation of the injured soldier took place at an undisclosed time and place on the frontline where the presence of Russian drones and landmines made it impractical to send in a wheeled ground robot, according to The Kyiv Independent. On October 19, Ukraine’s Army shared a video of the drone evacuation, showing the wounded soldier securing himself in a harness suspended beneath a heavy hexacopter drone with six rotors before being flown to safety.

“This is a historic event, the next stage of evacuating the wounded, which we will all come to,” said Napalm, a programmer of the 92nd separate assault brigade's unmanned ground systems company, who went by his callsign per Ukrainian military practice, in a statement. “Now the serious systematic work begins, so that such missions are carried out constantly.”

Read full article

Comments

Up to a quarter of active-duty Army members could receive a low testosterone result from mandatory military screening, despite the true prevalence of the condition likely being a tiny fraction of that figure, according to a study published Thursday in JAMA.

The finding adds to concerns that the mandatory screening announced by Defense Secretary Pete Hegseth in July will lead to a cascade of unnecessary medical evaluations for military members. Those evaluations could result in inappropriate testing, inaccurate results and diagnoses, and overtreatment that could cause harm, including infertility. Medical experts, including the Endocrine Society and the American Urological Association (AUA), have recommended against blanket screenings for these reasons. Still, the Pentagon has moved forward with the plans, releasing clinical guidance in September.

The JAMA study highlights the reasons why testosterone levels are not measured in men without symptoms—and also offers a glimpse of how many Army members could become ensnared in the clinically dubious screenings.

Read full article

Comments